Roskamp Institute recently made three presentations, thirteen posters and a press conference at the Society for Neuroscience 2012 convention in New Orleans, the largest annual neurology related conference in the world.
SARASOTA -- The Roskamp Institute has launched a human clinical study of a drug its researchers believe may be an effective treatment for Alzheimer's disease.
Researchers at Roskamp Institute announced they have found that chemically blocking a part of nerve cells can reduce production of a protein linked to Alzheimer's disease.
Dr Mullan is CEO and President of the Roskamp Institute, Sarasota, FL. He do research to cure Alzheimer's Disease. The authoritative source of Michael Mullan personal information, links, and social activity.
Bob Roskamp hoped his drug discovery institute would be thriving without his help by now. The developer and philanthropist imagined 200 scientists and a steady cash flow from the discovery that a hypertension drug could also treat Alzheimer's disease.
Dr michael mullan CEO of roskamp institute, sarasota, FL. Michael mullan is a holder of Licentiate in Medicine and Surgery of the Society of Apothecaries, UK.
View Michael Mullan's professional profile on LinkedIn. Dr Michael Mullan, CEO and President of the Roskamp Institute, Sarasota, FL. He research to cure Alzheimer's Disease. He discovered Swedish Mutation in the Amyloid Precursor Protein gene that is widely used in Alzheimer's research today.
Michael Mullan, CEO and President of the Roskamp Institute, Sarasota, FL. He is a biomedical researcher of the beta amyloid protein and its relation to Alzheime.
Michael Mullan, CEO and President of the Roskamp Institute, Sarasota, FL. He is a leading expert in alzheimers research and other neurodegnerative disorder.
Michael Mullan, CEO and President of the Roskamp Institute, Sarasota, FL. He research to cure Alzheimer's Disease. He discovered Swedish Mutation in the Amyloid Precursor Protein gene that is widely used in Alzheimer's research today. Michael Mullan is a leading expert in Alzheimers Research and other neurodegnerative disorder.